Ovarian protection and preserving fertility during treatment for gynaecological malignancies when children are desired;Ovarielle protektion und erhalt der fertilität im rahmen der therapie gynäkologischer malignome bei kinderwunsch

Gynakologische Endokrinologie

Volumn 3, Issue 2, 2005, Pages 107-114

  Von Wolff, M ^a   Eisenhardt, S ^a   Strowitzki, T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cytotoxic therapies; Desire for children; Gynaecological malignancies; Ovarian protection; Preserving fertility

Indexed keywords

GONADORELIN AGONIST;

ARTICLE; BREAST CARCINOMA; CRYOPRESERVATION; FEMALE; FERTILIZATION IN VITRO; GYNECOLOGIC CANCER; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; OVARY FUNCTION;

EID: 33646234932     PISSN: 16102894     EISSN: 16102908     Source Type: Journal    
DOI: 10.1007/s10304-005-0107-8     Document Type: Article

References (30)

1. Ayhan A, Celik H, Taskiran C et al. (2003) Oncologic and reproductive outcome after fertility-saving surgery in ovarian cancer. Eur J Gynaecol Oncol 24:223-232
2. Bernardini M, Barrett J, Seaward G, Covens A (2003) Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol 189:1378-1382
3. Bines J, Oleske DM, Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718-1729
4. Blumenfeld Z, Dann E, Avivi I et al. (2002) Fertility after treatment for Hodgkin's disease. Ann Oncol 13 [Suppl 1]:138-147
5. Bukman A, Heineman MJ (2001) Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 7:581-590
6. Cha KY, Han SY, Chung HM et al. (2000) Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome. Fertil Steril 73:978-983
7. Chian RC, Buckett WM, Tulandi T, Tan SL (2000) Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 15:165-170
8. Covens A, Shaw P, Murphy J et al. (1999) Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix? Cancer 86:2273-2279
9. Donnez J, Dolmans MM, Demylle D et al. (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364:1405-1410
10. Isachenko V, Montag M, Isachenko E et al. (2005) Aseptic technology of vitrification of human pronuclear oocytes using open-pulled straws. Hum Reprod 20:492-496
11. Jäger W, Bittl A, Rabenbauer B, Wildt L (1990) Chemotherapeutically induced amenorrhoea is associated with decreasing CA124 serum levels. In: Klapdor R (ed) Recent results in tumor diagnosis and therapy. Zuckschwerdt, München, pp 133-137
12. Johnson J, Canning J, Kaneko T et al. (2004) Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428:145-150
13. Kim SS, Soules MR, Battaglia DE (2002) Follicular development, ovulation, and corpus luteum formation in cryopreserved human ovarian tissue after xenotransplantation. Fertil Steril 78:77-82
14. Kimmig R, Strowitzki T, Muller-Hocker J et al. (1995) Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 58:255-257
15. Levine MN, Bramwell VH, Pritchard KI et al. (1998) Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 16:2651-2658
16. Mackie EJ, Radford M, Shalet SM (1996) Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 27:74-78
17. Meistrich ML, Byrne J (2002) Genetic disease in offspring of long-term survivors of childhood and adolescent cancer treated with potentially mutagenic therapies. Am J Hum Genet 70:1069-1071
18. Mikkelsen AL, Smith S, Lindenberg S (2000) Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation. Hum Reprod 15:1685-1690
19. Mitwally MF, Casper RF (2003) Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 18:1588-1597
20. Morice P, Camatte S, El Hassan J et al. (2001) Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 75:92-96
21. Oktay K, Buyuk E, Davis O et al. (2003) Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 18:90-95
22. Oktay K, Buyuk E, Rosenwaks Z (2003) Novel use of an aromatase inhibitor for fertility preservation via embryo cryopreservation in endometrial cancer: a case report. Fertil Steril 80 [Suppl 3]:144
23. Oktay K, Buyuk E, Veeck L et al. (2004) Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363:837-840
24. Paris F, Perez GI, Fuks Z et al. (2002) Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med 8:901-902
25. Pereyra Pacheco B, Mendez Ribas JM, Milone G et al. (2001) Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 81:391-397
26. Porcu E, Fabbri R, Maria Ciotti P et al. (2002) Oocytes or embryo storage? Fertil Steril 78 [Suppl 1]:O-38
27. Recchia F, Sica G, De Filippis S et al. (2002) Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anticancer Drugs 13:417-424
28. Sankila R, Heinavaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect". Am J Obstet Gynecol 170:818-823
29. Scott RT, Opsahl MS, Leonardi MR et al. (1995) Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 10:1706-1710
30. Wang CB, Wang CJ, Huang HJ et al. (2002) Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 94:2192-2198